Genpharmasec Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
No of Months
12
12
Profit Before Tax
0.00
0.00
Adjustment
0.00
0.00
Changes In working Capital
-3.00
-3.00
Cash Flow after changes in Working Capital
-2.00
-3.00
Cash Flow from Operating Activities
-2.00
-3.00
Cash Flow from Investing Activities
-28.00
0.00
Cash Flow from Financing Activities
47.00
3.00
Net Cash Inflow / Outflow
16.00
0.00
Opening Cash & Cash Equivalents
1.00
1.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
Closing Cash & Cash Equivalent
18.00
1.00
Compare Cash Flow Results of Genpharmasec
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
0.25
76.09
-76.00
-99.67%
Adjustment
0.39
44.83
-44.00
-99.13%
Changes In working Capital
-3.54
-78.27
75.00
95.48%
Cash Flow after changes in Working Capital
-2.91
42.64
-44.00
-106.82%
Cash Flow from Operating Activities
-2.95
40.34
-42.00
-107.31%
Cash Flow from Investing Activities
-28.06
-50.58
22.00
44.52%
Cash Flow from Financing Activities
47.85
25.25
22.00
89.50%
Net Cash Inflow / Outflow
16.84
15.01
1.00
12.19%
Opening Cash & Cash Equivalents
1.99
14.23
-13.00
-86.02%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
18.83
29.24
-11.00
-35.60%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 3.59% vs NA in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-2.95
-3.06
3.59%